医学
血运重建
背景(考古学)
数字减影血管造影
缺血
外科
推导
血管造影
德尔菲法
人口
适当的使用标准
适宜性标准
德尔菲
动脉疾病
重症监护医学
心脏病学
内科学
血管疾病
静脉
金标准(测试)
动脉
临床实习
灌注
放射科
肢体缺血
梅德林
疾病
搭桥手术
作者
Mario Alejandro Fabiani,Jos C. van den Berg,Oscar A. De la Torre,Alfredo Verastegui,Anahita Dua,Vlad Adrian Alexandrescu,Amanjit S. Baadh,Bahaa Nasr,Juan Guillermo Barrera Carvajal,Robert E. Beasley,Lukla Biasi,Theodosios Bisdas,Erwin Blessing,Stefano Bonvini,Marianne Brodmann,Gonçalo Cabral,Roberto Cancellieri,Caroline Caradu,Andrea Casini,Venita Chandra
摘要
INTRODUCTION: Revascularization to prevent limb loss is not feasible or represents a very high risk in a significant proportion of patients with chronic limb-threatening ischaemia (CLTI). No standard definition currently exists to define this population of patients. The aim of this study was to develop a consensus-based, multidomain definition to improve clinical assessment and reporting of studies in people with 'no option' (NO) or 'poor option' (PO) CLTI. METHODS: A modified Delphi process was conducted with 164 specialists from 30 countries. Two iterative survey rounds were used to reach consensus, defined as ≥70% agreement with a score of ≥7 on a nine-point scale. RESULTS: Some 164 international vascular specialists participated in the study, averaging 19 years of experience. A multidomain framework including arterial disease anatomy, biology, risk, function, and context (ABRFC) achieved 83% consensus. A 'desert foot' was defined as the absence of distal arterial revascularization targets on advanced non-invasive imaging, invasive digital subtraction angiography, and at least one failed endovascular revascularization attempt (81.6% agreement). Inadequate autogenous bypass conduit was defined as the lack of usable autologous vein across all four limbs (85% agreement). Patients were classified as NO for revascularization if they present with 'desert foot', prohibitive medical risk, a non-functional limb, or in those patients who refused arterial revascularization. PO revascularization patients combined factors such as severe infection, lack of autologous vein, or treatment non-compliance (72.1% agreement). CONCLUSION: This consensus study established a structured, expert-validated definition of no option or poor option for revascularisation of patients with CLTI. The multidomain ABRFC framework provides a foundation for standardized clinical assessment, trial design, and future guideline development.
科研通智能强力驱动
Strongly Powered by AbleSci AI